ImmunityBio, Inc. (NASDAQ:IBRX) is one of the best penny stocks to buy for 2026. On December 16, ImmunityBio, Inc.
The American Cancer Society estimates that over 80,000 individuals will be diagnosed with bladder cancer this year.
The Saudi Food and Drug Authority (SFDA) has granted conditional approval for Anktiva, a groundbreaking cancer therapy, for ...
Lancaster Guardian on MSN
Kirkby Lonsdale mum-of-two is first in region to be given groundbreaking new bladder cancer treatment
A mum-of-two from Kirkby Lonsdale has become the first patient in the region to receive innovative treatment for bladder ...
Pfizer Inc. (NYSE:PFE) is one of the most buzzing stocks to invest in according to hedge funds. Earlier on December 17, ...
New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...
News Nation on MSN
Patrick Soon-Shiong’s cancer drug approved by Saudi FDA
Dr. Soon-Shiong is hopeful the Saudi Arabian FDA's approval of his cancer therapy drug, Anktiva, will lead to widespread ...
Overall survival is no better for patients diagnosed with NMIBC who progress directly to metastasis.
Saudi Gazette on MSN
SFDA approves registration of 'Anktiva' for treatment of bladder and lung cancer
The Saudi Food and Drug Authority (SFDA) has granted conditional approval for Anktiva (nogapendekin alfa inbakicept) in ...
James Stewart loves being active. He enjoys rollerblading and paddle boarding. He jumps off cliffs and bridges into lakes. "I had never been sick a day in my life," said Stewart, who lives in Round ...
The collaborative clinical study will evaluate ADSTILADRIN® (nadofaragene firadenovec-vncg) in combination with the investigational drug Ruvidar® (TLD-1433) in patients with Bacillus ...
Scientists warn only one type of cancer - with common symptoms which make it hard to diagnose - is becoming more deadly in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback